Red blood cells treated with the S-303 system for pathogen inactivation demonstrate in vitro characteristics suitable for transfusion: phase III clinical trial in cardiac surgery patients

• Brixner V ;
• Leibacher J ;
• Pfeiffer H-U ;
• Muller MM ;
• Geisen C ;
• Henschler R ;
• Janetzko K ;
• Heldke S ;
• Huang N ;
• Ernst C ;
• Rico S ;
• Erickson A ;
• Mufti N ;
• Corash L ;
• Seifried E